Drug:
Reaction: DRY SKIN
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25491890 |
US |
87 | 1 |
Acne, Dry skin, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 2 | 25491915 |
US |
33 | 1 |
Dry skin, Eczema, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 3 | 25491918 |
US |
47 | 2 |
Rebound eczema, Pruritus, Dry skin, Therapeutic response shortened, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 4 | 25493633 |
US |
21 | 2 |
Emotional distress, Pupillary reflex impaired, Aggression, Agitation, Dry skin, Sinus tachycardia, Hallucination, visual, Nausea, Vomiting, Overdose, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 5 | 25495346 |
CN |
40 | 1 |
Skin exfoliation, Dry skin, Fungal test positive, |
||||
IXEKIZUMAB, IXEKIZUMAB, IXEKIZUMAB, |
||||
| 6 | 25495563 |
US |
64 | 1 |
Pruritus, Skin fissures, Skin haemorrhage, Dry skin, |
||||
DUPILUMAB, |
||||
| 7 | 25495571 |
US |
43 | 1 |
Dry skin, Pruritus, Skin exfoliation, Dry eye, |
||||
DUPILUMAB, |
||||
| 8 | 25495626 |
US |
3 | 2 |
Dry skin, Pruritus, Conjunctivitis, Dry eye, |
||||
DUPILUMAB, |
||||
| 9 | 25495678 |
US |
14 | 2 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 10 | 25495707 |
US |
28 | 2 |
Eczema, Dry skin, Skin hyperpigmentation, Pruritus, Skin fissures, Maternal exposure during pregnancy, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 11 | 25495721 |
US |
62 | 1 |
Dry skin, Skin haemorrhage, Skin fissures, Pruritus, |
||||
DUPILUMAB, |
||||
| 12 | 25495743 |
US |
35 | 1 |
Sleep disorder, Blister, Pain of skin, Skin fissures, Skin haemorrhage, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 13 | 25495760 |
US |
81 | 1 |
Pruritus, Dry skin, Illness, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 14 | 25495797 |
US |
20 | 2 |
Sleep disorder due to a general medical condition, Pruritus, Skin fissures, Skin exfoliation, Dry skin, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 15 | 25495810 |
US |
26 | 2 |
Dry skin, Skin exfoliation, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 16 | 25495814 |
US |
15 | 2 |
Dermatitis atopic, Pruritus, Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 17 | 25495874 |
US |
56 | 1 |
Dry skin, Pruritus, Injection site pain, Product preparation error, |
||||
DUPILUMAB, |
||||
| 18 | 25495902 |
US |
31 | 2 |
Dry skin, Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 19 | 25495908 |
US |
59 | 1 |
Pruritus, Dry skin, |
||||
DUPILUMAB, |
||||
| 20 | 25495909 |
US |
3 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 21 | 25495914 |
US |
42 | 2 |
Periorbital swelling, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Skin exfoliation, Ocular hyperaemia, Pruritus, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 22 | 25495916 |
US |
82 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 23 | 25495918 |
US |
73 | 1 |
Nasal dryness, Dry skin, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 24 | 25495962 |
US |
18 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 25 | 25496027 |
PA |
64 | 2 |
Breast cancer, Malignant neoplasm progression, Breast discomfort, Rash vesicular, Skin discolouration, Dry skin, Blister rupture, Pruritus, Pruritus, Hypersensitivity, Rash, Drug ineffective, |
||||
FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 26 | 25490945 |
US |
8 | 2 |
Dermatitis atopic, Dry skin, Pruritus, Skin fissures, |
||||
DUPILUMAB, |
||||
| 27 | 25490981 |
US |
81 | 2 |
Nausea, Dry skin, Skin haemorrhage, Scab, Pruritus, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 28 | 25490994 |
US |
80 | 1 |
Pruritus, Dry skin, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 29 | 25491018 |
US |
19 | 2 |
Dry skin, Sleep disorder due to a general medical condition, Pruritus, |
||||
DUPILUMAB, |
||||
| 30 | 25491069 |
US |
58 | 1 |
Sleep disorder due to a general medical condition, Dry skin, Erythema, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 31 | 25491229 |
US |
68 | 1 |
Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 32 | 25491279 |
US |
22 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 33 | 25491281 |
US |
6 | 2 |
Condition aggravated, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 34 | 25491292 |
US |
2 | 1 |
Eczema, Pruritus, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 35 | 25491316 |
US |
47 | 2 |
Dry skin, Skin exfoliation, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 36 | 25491340 |
US |
54 | 2 |
Dry skin, Sleep disorder due to a general medical condition, Pruritus, |
||||
DUPILUMAB, |
||||
| 37 | 25491429 |
US |
65 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 38 | 25491497 |
US |
21 | |
Dry skin, Sunburn, Back pain, Lip dry, Photosensitivity reaction, |
||||
ISOTRETINOIN, |
||||
| 39 | 25489960 |
US |
2 | |
Dry skin, |
||||
DUPILUMAB, |
||||
| 40 | 25490034 |
US |
2 | |
Pruritus, Therapeutic response decreased, Dry skin, Skin fissures, Skin exfoliation, |
||||
DUPILUMAB, TRALOKINUMAB-LDRM, UPADACITINIB, |
||||
| 41 | 25490043 |
US |
16 | 1 |
Dry skin, Rash erythematous, Pruritus, |
||||
DUPILUMAB, |
||||
| 42 | 25490150 |
CA |
62 | 2 |
Tardive dyskinesia, Abnormal behaviour, Lip swelling, Hypersensitivity, Dysphagia, Peripheral swelling, Psoriasis, Tremor, Mouth swelling, Dry skin, Blood glucose increased, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 43 | 25490224 |
US |
20 | 1 |
Dry skin, Skin fissures, Product dose omission issue, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 44 | 25490306 |
US |
20 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 45 | 25490333 |
US |
19 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 46 | 25490336 |
US |
47 | 2 |
Dry skin, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 47 | 25490338 |
US |
50 | 2 |
Eczema, Dry skin, Skin exfoliation, Pruritus, Dry eye, |
||||
DUPILUMAB, |
||||
| 48 | 25490350 |
US |
25 | 1 |
Dry skin, Pruritus, Sleep disorder, |
||||
DUPILUMAB, |
||||
| 49 | 25490365 |
US |
33 | 1 |
Dry skin, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 50 | 25490366 |
US |
2 | |
Weight increased, Skin exfoliation, Dry skin, Pruritus, |
||||
DUPILUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LATANOPROST, RUXOLITINIB, SILVER SULFADIAZINE, |
||||
| 51 | 25490409 |
US |
12 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 52 | 25490452 |
US |
34 | 1 |
Injection site pain, Dry skin, Skin fissures, Skin haemorrhage, Sunburn, Pruritus, Sleep disorder due to a general medical condition, Dry eye, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 53 | 25490492 |
US |
54 | 1 |
Rash pruritic, Dry skin, Insomnia, |
||||
DUPILUMAB, |
||||
| 54 | 25490918 |
US |
18 | 1 |
Dry skin, Skin fissures, Pruritus, |
||||
DUPILUMAB, |
||||
| 55 | 25500379 |
15 | 1 | |
Swelling, Erythema, Pruritus, Dry skin, Skin exfoliation, |
||||
OFLOXACIN, OFLOXACIN OTIC, OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%, OFLOXACIN OTIC SOLUTION, |
||||
| 56 | 25484663 |
36 | 1 | |
Alopecia, Therapy cessation, Oesophageal achalasia, Dry skin, Semen viscosity decreased, Feeling abnormal, Feeling cold, Sexual dysfunction, Genital discolouration, Hair texture abnormal, Pain, Hair texture abnormal, Alopecia, Hair growth abnormal, Disturbance in attention, Disturbance in attention, Seborrhoea, |
||||
FINASTERIDE, ERGOCALCIFEROL, |
||||
| 57 | 25486436 |
US |
61 | 1 |
Pruritus, Dry skin, Skin weeping, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 58 | 25487096 |
GB |
69 | 2 |
Acute kidney injury, Overdose, Polyuria, Hypotension, International normalised ratio abnormal, Dialysis, Medication error, Amnesia, Abdominal pain upper, Nausea, Blindness, Abdominal discomfort, Tinnitus, Palmoplantar keratoderma, Atrial tachycardia, Dry skin, Immunisation, Tension headache, Alopecia, Diarrhoea, Angioedema, Headache, Hallucination, COVID-19, Dizziness, Arthralgia, Pain of skin, Peripheral swelling, Disturbance in attention, Cognitive disorder, Memory impairment, Visual impairment, Diplopia, Vasculitis, Carotid artery occlusion, Transient ischaemic attack, Pruritus genital, Subarachnoid haemorrhage, Sleep terror, Vomiting, Ventricular tachycardia, Pericarditis, Cardiospasm, Dyspnoea, Fatigue, Anxiety, Muscular weakness, Feeling abnormal, Insomnia, Heart rate increased, Blood glucose increased, Muscle twitching, Dehydration, Pyrexia, Hyperhidrosis, Chest pain, Back pain, Rash, Lip swelling, Pruritus, Myocardial infarction, Palpitations, Tachycardia, Pain, Anosmia, Eye pruritus, Facial pain, Migraine, Malaise, Intentional product use issue, Intentional product misuse, Incorrect product administration duration, Medication error, Off label use, |
||||
OLANZAPINE, OLANZAPINE, OLANZAPINE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, ARIPIPRAZOLE, ARIPIPRAZOLE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, LITHIUM CARBONATE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, WARFARIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, WARFARIN SODIUM, WARFARIN, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, APIXABAN, APIXABAN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, SIMVASTATIN, SIMVASTATIN, DAPAGLIFLOZIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, DIGOXIN, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, ISOSORBIDE DINITRATE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, LINAGLIPTIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CANDESARTAN CILEXETIL, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, SIMVASTATIN, NAPROXEN, NAPROXEN SODIUM, AMITRIPTYLINE HYDROCHLORIDE, ESTRIOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, INSULIN GLARGINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUMETANIDE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 59 | 25487167 |
US |
61 | 2 |
Dry skin, |
||||
SIROLIMUS, MELOXICAM, MELATONIN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 60 | 25487911 |
GB |
||
Joint swelling, Erythema, Dry skin, Oedema blister, |
||||
FULVESTRANT, PALBOCICLIB, |
||||
| 61 | 25488819 |
PL |
68 | 1 |
Neutropenia, Metastases to liver, Metastases to peritoneum, Metastases to lymph nodes, Dry skin, Rash maculo-papular, Therapy partial responder, |
||||
FILGRASTIM, PANITUMUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, |
||||
| 62 | 25489099 |
US |
59 | 1 |
Dermatitis, Dry skin, Acne, Asthma, Therapeutic response shortened, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 63 | 25489120 |
US |
76 | 2 |
Dry skin, Erythema, Dermatitis atopic, Pruritus, |
||||
DUPILUMAB, |
||||
| 64 | 25489142 |
US |
1 | |
Scratch, Dry skin, Therapeutic response decreased, |
||||
DUPILUMAB, ABROCITINIB, |
||||
| 65 | 25489158 |
US |
38 | 1 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 66 | 25489204 |
US |
56 | 2 |
Memory impairment, Dry skin, Pruritus, Eyelids pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 67 | 25489213 |
US |
40 | 2 |
Dry skin, Sleep disorder, |
||||
DUPILUMAB, |
||||
| 68 | 25489243 |
US |
48 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 69 | 25489304 |
US |
3 | 1 |
Dry skin, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 70 | 25489327 |
US |
6 | 2 |
Pruritus, Dry skin, Oral herpes, |
||||
DUPILUMAB, |
||||
| 71 | 25489350 |
US |
69 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 72 | 25489360 |
US |
30 | 2 |
Sleep disorder due to a general medical condition, Dry skin, Skin exfoliation, Pruritus, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 73 | 25489369 |
US |
26 | 2 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 74 | 25489371 |
US |
95 | 1 |
Dry skin, Pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 75 | 25489420 |
US |
51 | 2 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 76 | 25489426 |
US |
31 | 2 |
Dry skin, Eyelid injury, Pruritus, Dry eye, |
||||
DUPILUMAB, |
||||
| 77 | 25489429 |
US |
36 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 78 | 25489434 |
US |
66 | 2 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 79 | 25489437 |
US |
22 | 1 |
Dermatitis atopic, Rash, Dry skin, Product dose omission issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 80 | 25489461 |
US |
58 | 1 |
Rebound atopic dermatitis, Pruritus, Dry skin, Skin exfoliation, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 81 | 25489462 |
US |
52 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 82 | 25489606 |
US |
35 | 2 |
Dry skin, Pruritus, Exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 83 | 25489689 |
US |
85 | 2 |
Type 2 diabetes mellitus, Peripheral swelling, Pain in extremity, Erythema, Ageusia, Anosmia, Impaired healing, Scratch, Scab, Dry skin, Product dose omission issue, |
||||
LORLATINIB, ALLOPURINOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATENOLOL, CALCIUM CARBONATE, ANTACID, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, DENOSUMAB, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, EZETIMIBE, FUROSEMIDE, GABAPENTIN, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, MAGNESIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MUPIROCIN, MUPIROCIN CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, STANDARDIZED SENNA CONCENTRATE, TORSEMIDE, ERGOCALCIFEROL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 84 | 25489736 |
US |
||
Dry skin, |
||||
ADAPALENE, |
||||
| 85 | 25489737 |
US |
||
Erythema, Skin irritation, Dry skin, Skin exfoliation, Pruritus, Skin burning sensation, Dermatitis, Drug ineffective, Inappropriate schedule of product administration, Underdose, |
||||
ADAPALENE, ADAPALENE, |
||||
| 86 | 25489913 |
US |
9 | 1 |
Dry skin, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 87 | 25490471 |
US |
19 | 1 |
Dry skin, Periorbital eczema, Skin exfoliation, Pruritus, Rash, Eye pruritus, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 88 | 25490596 |
US |
10 | 1 |
Dry skin, Rash, |
||||
DUPILUMAB, |
||||
| 89 | 25490729 |
US |
58 | 1 |
Dermatitis atopic, Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 90 | 25490802 |
US |
43 | 2 |
Dry skin, Skin exfoliation, Dermatitis atopic, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 91 | 25494343 |
68 | 1 | |
Dry skin, |
||||
LENALIDOMIDE, |
||||
| 92 | 25482998 |
CA |
2 | |
Bone pain, Joint ankylosis, Pain, Panic attack, Stress, Tremor, Photosensitivity reaction, Anxiety, Depressed mood, Suicidal ideation, Hyperhidrosis, Dry skin, |
||||
ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, |
||||
| 93 | 25483904 |
US |
60 | 2 |
Dyspnoea, Decreased appetite, Dry skin, Rash, Nausea, |
||||
PALBOCICLIB, AMLODIPINE BESYLATE, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 94 | 25484185 |
US |
19 | 1 |
Rebound eczema, Erythema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 95 | 25484317 |
US |
21 | 2 |
Hallucination, visual, Sinus tachycardia, Electrocardiogram QT prolonged, Dry skin, Aggression, Overdose, Vomiting, Flushing, Nausea, Delirium, Agitation, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 96 | 25484327 |
US |
17 | 2 |
Dry skin, |
||||
DUPILUMAB, |
||||
| 97 | 25484334 |
US |
33 | 2 |
Dry skin, Pruritus, |
||||
DUPILUMAB, |
||||
| 98 | 25484434 |
US |
22 | 2 |
Eczema, Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 99 | 25484912 |
US |
31 | 1 |
Death, Dry skin, Skin hypertrophy, Skin atrophy, Throat irritation, Pain, Muscle tightness, Gastrointestinal disorder, Myalgia, Back pain, Dysphonia, Fatigue, Proteinuria, |
||||
FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, DIPHENHYDRAMINE HYDROCHLORIDE, CLONAZEPAM, HYDROXYZINE, MORPHINE SULFATE, OXYCODONE, PANTOPRAZOLE, ERGOCALCIFEROL, SERTRALINE, |
||||
| 100 | 25485357 |
US |
35 | 1 |
Rebound eczema, Erythema, Dry skin, Skin fissures, Pruritus, Injection site pain, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29